Background: Minoxidil (Mx) is known to induce hair growth in men with
male-pattern baldness. Based on this potential, the effectiveness of M
x 2% topical solution was evaluated in cancer patients (pts) to preven
t doxorubicin-induced alopecia. Patients and methods: 48 female pts wi
th different types of solid tumors treated with doxorubicin-based chem
otherapy in a dose range of 50-60 mg/m2/cycle were randomly assigned t
o receive Mx 2% topical solution or placebo. Results: 88% and 92% of p
ts in both arms showed severe alopecia (p = ns). No adverse effects we
re observed. Conclusion: In this study Mx 2% topical solution was non-
toxic but was not effective in the prevention of chemotherapy-induced
alopecia.